Fig. 1
Fibroblast growth factor (FGF)-23 and its effect on cardiac fibroblast activity.
FGF receptor 1 (FGFR1), phospholipase C (PLC), inositol 1,4,5-trisphosphate (IP3), calcium channel protein 1 (Orai1), IP3 receptor (IP3R)
Cardiac fibrosis and atrial fibrillation
DOI: https://doi.org/10.2478/ahem-2022-0035 | Journal eISSN: 1732-2693
Language: English
Page range: 307 - 314
Submitted on: Oct 28, 2021
Accepted on: Mar 28, 2022
Published on: Jul 11, 2022
Published by: Hirszfeld Institute of Immunology and Experimental Therapy
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Related subjects:
© 2022 Klaudia Katarzyna Mickiewicz, Anna Lisowska, Małgorzata Knapp, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.